"I believe Emisphere could sell the B12 pill for $100-$125 million if they took to the phone. Other potential candidates are Teva Pharmaceuticals (TEVA), Nature's Bounty (Private), Abbott Laboratories (ABT), Forest Laboratories (FRX) and Bristol Myers (BMY)."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.